Skip to search formSkip to main contentSkip to account menu

Boostrix

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
BACKGROUND We estimated the vaccine effectiveness (VE) of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing… 
Review
2012
Review
2012
SummaryAbstractBoostrix® is a three-pertussis component, combined, reduced-antigen content tetanus, diphtheria, and acellular… 
2011
2011
  • MMWR. Morbidity and mortality weekly report
  • 2011
  • Corpus ID: 21322585
On July 8, 2011, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced… 
2011
2011
  • Yan MaMin Qin Ming Sun
  • Zhonghua shi yan he lin chuang bing du xue za zhi…
  • 2011
  • Corpus ID: 1602266
OBJECTIVE In order to search the preparation process and optimazing dosage ratio of adsorbed diphtheria-tetanus-acellular… 
2010
2010
Pertussis continues to circulate in Chinese communities and older children, adolescents and adults are sources of infection for… 
Review
2009
Review
2009
Pertussis remains a serious problem in many countries. Even in countries with high vaccine coverage and a long vaccination… 
2009
2009
  • MMWR. Morbidity and mortality weekly report
  • 2009
  • Corpus ID: 30102812
On December 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced… 
2005
2005
  • T. Jones
  • IDrugs : the investigational drugs journal
  • 2005
  • Corpus ID: 25236141
GlaxoSmithKline plc has developed and launched Boostrix, a subunit vaccine for use in adolescents and adults as a booster…